Showing results (171-180 of 196) with videos related to
Sort By:
Pageof 20
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
High levels of common cold coronavirus antibodies in convalescent plasma are associated with improved survival in COVID-19 patientsUri Greenbaum, Kimberly Klein, Fernando Martinez, et al.Journal of the National Cancer Institute|February 27, 2009
Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancerDimitra Tsavachidou, Timothy J McDonnell, Sijin Wen, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 30, 2017
Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancerSteven H Lin, Kenneth W Merrell, Jincheng Shen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomasPeter W T Pisters, Shreyaskumar R Patel, Victor G Prieto, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized studySimrit Parmar, Borje S Andersson, Daniel Couriel, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 15, 2015
Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory LymphomasYago Nieto, Benigno C Valdez, Peter F Thall, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Platelet-derived growth factor receptor inhibition and chemotherapy for castration-resistant prostate cancer with bone metastasesPaul Mathew, Peter F Thall, Corazon D Bucana, et al.Cancer|May 21, 2016
Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphomaYago Nieto, Benigno C Valdez, Peter F Thall, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2016
Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic SyndromeGheath Alatrash, Peter F Thall, Benigno C Valdez, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 5, 2018
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin LymphomaYago Nieto, Peter F Thall, Junsheng Ma, et al.Pageof 20